Integer Holdings Co. (NYSE:ITGR - Free Report) - Equities research analysts at Zacks Research boosted their FY2024 EPS estimates for Integer in a research note issued on Thursday, November 14th. Zacks Research analyst D. Dey now expects that the medical equipment provider will post earnings per share of $5.32 for the year, up from their prior estimate of $5.28. The consensus estimate for Integer's current full-year earnings is $5.34 per share. Zacks Research also issued estimates for Integer's Q4 2024 earnings at $1.45 EPS, Q1 2025 earnings at $1.30 EPS, Q2 2025 earnings at $1.45 EPS, Q4 2025 earnings at $1.69 EPS, FY2025 earnings at $5.99 EPS, Q1 2026 earnings at $1.63 EPS and Q2 2026 earnings at $1.57 EPS.
Integer (NYSE:ITGR - Get Free Report) last posted its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million for the quarter, compared to analysts' expectations of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company's quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.27 EPS.
Several other analysts have also commented on the stock. KeyCorp lifted their price objective on shares of Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 15th. Truist Financial reduced their price objective on Integer from $150.00 to $147.00 and set a "buy" rating for the company in a report on Friday, October 25th. Citigroup boosted their target price on Integer from $124.00 to $130.00 and gave the company a "neutral" rating in a research note on Tuesday, October 1st. Piper Sandler reiterated an "overweight" rating and set a $140.00 price target (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. Finally, Bank of America boosted their price objective on Integer from $135.00 to $145.00 and gave the company a "buy" rating in a research note on Tuesday, October 1st. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Integer has an average rating of "Moderate Buy" and an average target price of $139.75.
Read Our Latest Stock Analysis on Integer
Integer Stock Performance
Shares of Integer stock traded up $1.37 during trading hours on Monday, hitting $134.55. 662,066 shares of the company's stock traded hands, compared to its average volume of 311,893. The stock has a market capitalization of $4.51 billion, a price-to-earnings ratio of 41.10, a PEG ratio of 1.91 and a beta of 1.09. Integer has a 12-month low of $84.75 and a 12-month high of $140.91. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. The company has a fifty day simple moving average of $129.20 and a 200-day simple moving average of $122.75.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of ITGR. ProShare Advisors LLC increased its stake in Integer by 7.4% in the 1st quarter. ProShare Advisors LLC now owns 6,698 shares of the medical equipment provider's stock worth $782,000 after purchasing an additional 461 shares during the period. State Board of Administration of Florida Retirement System raised its holdings in Integer by 12.9% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 10,705 shares of the medical equipment provider's stock valued at $1,249,000 after buying an additional 1,220 shares during the last quarter. Vanguard Group Inc. grew its holdings in Integer by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider's stock worth $446,428,000 after acquiring an additional 23,382 shares during the last quarter. UniSuper Management Pty Ltd purchased a new position in shares of Integer in the first quarter valued at about $976,000. Finally, CANADA LIFE ASSURANCE Co raised its stake in shares of Integer by 4.0% during the first quarter. CANADA LIFE ASSURANCE Co now owns 35,068 shares of the medical equipment provider's stock valued at $4,091,000 after acquiring an additional 1,361 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.
About Integer
(
Get Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
See Also
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
